市場調查報告書

全球乾眼症市場:2019年∼2025年的預測

Global Dry Eye Disease Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 920418
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球乾眼症市場:2019年∼2025年的預測 Global Dry Eye Disease Market 2019-2025
出版日期: 2019年11月12日內容資訊: 英文
簡介

全球乾眼症市場在預測期間內預計將以4.6%的年複合成長率成長。該市場成長的重要要素,是乾眼症症候群的盛行率大幅度上升,乾眼症的認識提高宣傳活動。

本報告提供全球乾眼症市場的相關調查,市場機會和趨勢,成長及阻礙因素,各類型、治療方法、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

  • 調查方法與工具
  • 市場分析
    • 各市場區隔
    • 各地區

第2章 市場概要、洞察

  • 報告的範圍
  • 分析師的洞察及目前市場趨勢
    • 主要調查結果
    • 建議
    • 結論
  • 規則、規定

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Novartis AG
    • Allergan PLC
    • Johnson & Johnson Vision Care, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • Bausch Health Companies, Inc.

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各類型
    • 水性
    • 汽化性
  • 各治療法
    • 抗發炎藥
    • 人工眼淚
    • 淚點塞
    • 分泌促進物質

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • AFT Pharmaceuticals
  • Akorn, Inc. (Fresenius SE & Co. KGaA)
  • Allergan PLC
  • Bausch Health Companies, Inc.
  • Beaver-Visitec International Holdings, Inc.
  • FCI Ophthalmics
  • I-MED Pharma, Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Medennium, Inc.
  • Novaliq GmbH
  • Novartis AG
  • OASIS Medical, Inc.
  • 大塚製藥株式會社
  • Pfizer, Inc.
  • ROHTO製藥株式會社
  • 參天製藥株式會社
  • Scope Ophthalmics, Ltd.
  • Sentiss Pharma Pvt. Ltd.
  • Sun Pharmaceutical Industries, Ltd.
  • URSAPHARM Arzneimittel GmbH
  • VISUfarma
目錄
Product Code: OMR2020016

The global dry eye disease market is estimated to grow at a CAGR of 4.6% during the forecast period. Some crucial factors contributing to the growth of the market include a significant rise in the prevalence of dry eye syndrome and growing awareness campaigns for dry eye disease. There are certain awareness programs for dry eye syndrome. For instance, in May 2018, Alcon, a division of Novartis introduced the multimedia campaign, partnering with Venus Williams, a tennis champion. It is an educational campaign, which is intended to reach 30 million people suffering from dry eye syndrome in the US. Through this campaign, the company aims to promote its Systane family of lubricant eye drops.

Further, in August 2016, Shire PLC introduced Eyelove campaign by featuring Jennifer Aniston (Actress). The campaign aims to promote its dry-eye disease treatment, Xiidra in the US. These kinds of campaigns are supporting to create awareness among people for dry eye syndrome and thereby leads to the adoption of treatment alternatives for the condition. Based on geography, the global dry eye disease market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North American dry eye disease market is growing significantly owing to the emerging demand for contact lenses in the region. Asia-Pacific is estimated to witness potential growth in the market during the forecast period owing to the increasing focus of dry eye syndrome treatment providers to expand their therapeutic options to the region.

Key players in the global dry eye disease market include Novartis AG, Allegan PLC, Johnson & Johnson Vision Care, Inc., Santen Pharmaceutical Co., Ltd., and Bausch Health Companies, Inc. Mergers and acquisitions, product launches, and partnerships and collaborations are some key strategies adopted by the market players to stay competitive in the market. For instance, in June 2018, Bausch + Lomb declared the introduction of Soothe Xtra Protection (XP) Preservative Free lubricant eye drops. With this product launch, the company has widened the portfolio of eye health products to meet the emerging demand for dry eye symptom relief without using preservatives.

Research Methodology

The market study of the global dry eye disease market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the analysis is provided by analyzing various players, tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for providers of ophthalmic drugs and device manufacturers and government agencies, for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Dry Eye Disease Market Research and Analysis, By Type
  • Global Dry Eye Disease Market Research and Analysis, By Treatment

The Report covers:

  • Comprehensive research methodology of the global dry eye disease market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regulations and other government policies impacting the global dry eye disease market.
  • Insights about market determinants which are stimulating the global dry eye disease market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Novartis AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Allergan PLC
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Johnson & Johnson Vision Care, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Santen Pharmaceutical Co., Ltd.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Bausch Health Companies, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

4.1 Motivators

4.2 Restraints

4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Dry Eye Disease Market by Type
    • 5.1.1. Aqueous
    • 5.1.2. Evaporative
  • 5.2. Global Dry Eye Disease Market by Treatment
    • 5.2.1. Anti-Inflammatory Drugs
      • 5.2.1.1. Lifitegrast
      • 5.2.1.2. Corticosteroid
      • 5.2.1.3. Cyclosporine
    • 5.2.2. Artificial Tears
    • 5.2.3. Punctal Plug
    • 5.2.4. Secretagogue

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AFT Pharmaceuticals
  • 7.2. Akorn, Inc. (Fresenius SE & Co. KGaA)
  • 7.3. Allergan PLC
  • 7.4. Bausch Health Companies, Inc.
  • 7.5. Beaver-Visitec International Holdings, Inc.
  • 7.6. FCI Ophthalmics
  • 7.7. I-MED Pharma, Inc.
  • 7.8. Johnson & Johnson Vision Care, Inc.
  • 7.9. Medennium, Inc.
  • 7.10. Novaliq GmbH
  • 7.11. Novartis AG
  • 7.12. OASIS Medical, Inc.
  • 7.13. Otsuka Pharmaceutical Co., Ltd.
  • 7.14. Pfizer, Inc.
  • 7.15. Rohto Pharmaceutical Co., Ltd.
  • 7.16. Santen Pharmaceutical Co., Ltd.
  • 7.17. Scope Ophthalmics, Ltd.
  • 7.18. Sentiss Pharma Pvt. Ltd.
  • 7.19. Sun Pharmaceutical Industries, Ltd.
  • 7.20. URSAPHARM Arzneimittel GmbH
  • 7.21. VISUfarma

List of Tables

  • 1. GLOBAL DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL AQUEOUS DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL EVAPORATIVE DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 5. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL ARTIFICIAL TEARS FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL PUNCTAL PLUG FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL SECRETAGOGUE FOR DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 10. NORTH AMERICAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. NORTH AMERICAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 13. EUROPEAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 14. EUROPEAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 15. EUROPEAN DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 16. ASIA-PACIFIC DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. ASIA-PACIFIC DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 19. REST OF THE WORLD DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 20. REST OF THE WORLD DRY EYE DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL DRY EYE DISEASE MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL DRY EYE DISEASE MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 3. GLOBAL DRY EYE DISEASE MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD DRY EYE DISEASE MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top